본문 바로가기

company

History

Creating a bright future through challenges and changes.

Global Expansion ( 2011~ )

2019
  • Merge of ATGen and NKMAX Co., Ltd. / Changed the company name to “NKMAX.”
  • Clinical Phase 1 approved for Immunotherapy SuperNK® in the U.S.
  • Clinical Phase 1/2a approved for Immunotherapy SuperNK® in Korea.
  • Patent registration completed for NK VUE (3 patents, abroad)
2018
  • NK VUE product approval in Indonesia, Kazakhstan, and Singapore
  • NK VUE supply agreement signed with major Canadian diagnostics laboratories
  • Patent registration completed for NK VUE (1 patent, abroad)
  • Patent registration completed for SuperNK (2 patents, abroad)
  • Partnership agreement signed with Fukuoka Clinic
2017
  • NK VUE supply agreement signed with USA, Indonesia, and Kazakhstan
  • NK VUE supply agreement signed with major commercial laboratories in Korea
  • NK VUE product approval in Thailand and product approval / public reimbursement in Turkey
  • Patent registration completed for NK VUE (1 patent, abroad)
  • Set up a corporation office in USA (NKMAX America)
  • Set up a corporation office in Japan (NKMAX Japan)
2016
  • Patent for NK cell culture and treatment technology acquisition (SuperNK)
  • ATGen H&D, an ATGen subsidiary company, was founded
  • NKMAX, an ATGen affiliate company, was founded
  • NK VUE public reimbursement in Korea
  • Patent registration completed for NK VUE (2 patents, abroad)
2015
  • Listed on KOSDAQ with a special case of technology
2014
  • Set up a corporation office in Canada (ATGen Canada)
  • New Health Technology approved in Korea/ NK VUE approved in Canada
  • GMP certificate/ Canada ISO certification
  • Europe CE certification
  • Patent registration completed for NK VUE (1 patent, Korea)
2013
  • Selected as promising SME by Gyeonggi Province
  • Europe ISO 13485 certification (NK VUE)
  • Patent registration completed for NK VUE (1 patent, Korea)
2012
  • Overseas revenue $1M
  • PCT Patent registration for NK VUE (1 patent)

Growth ( 2006 - 2010 )

2009
  • Developed test kit for influenza enzyme linked immunosorbent assay
  • Established Direct online sales system
2007
  • INNO-BIZ Certified
2006
  • Designated as a Promising Export Company

Building Foundation ( Start - 2005 )

2005
  • Patent registration completed for SP fusion technology (1 patent, Korea)
2004
  • R&D center certification
2003
  • Venture Company Certification
  • Founded ATGen

Move to Top